Opinion
2022-2124
10-11-2023
TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellees v. ZYDUS PHARMACEUTICALS (USA) INC., CADILA HEALTHCARE LTD., Defendants-Appellants
ERIC J. LOBENFELD, Cherry Hill, NJ, argued for plain-tiffs-appellees. Also represented by BENJAMIN HOLT, RYAN STEPHENSON, Hogan Lovells U.S. LLP, Washington, DC. STEVEN J. MOORE, Withers Bergman LLP, Greenwich,CT, argued for defendants-appellants. Also represented by JAMES EDWARD NEALON, Nealon Law LLC, Stamford, CT.
This disposition is nonprecedential.
Appeal from the United States District Court for the District of New Jersey in No. 3:18-cv-11792-FLW-TJB, Judge Freda L. Wolfson.
ERIC J. LOBENFELD, Cherry Hill, NJ, argued for plain-tiffs-appellees. Also represented by BENJAMIN HOLT, RYAN STEPHENSON, Hogan Lovells U.S. LLP, Washington, DC.
STEVEN J. MOORE, Withers Bergman LLP, Greenwich,CT, argued for defendants-appellants. Also represented by JAMES EDWARD NEALON, Nealon Law LLC, Stamford, CT.
JUDGMENT
THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM
MOORE, Chief Judge, STOLL and CUNNINGHAM, Circuit Judges.
AFFIRMED. See Fed. Cir. R. 36.